West Family Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
West Family Investments's BMY Position: Q2 2026 in Review
West Family Investments increased its Bristol-Myers Squibb (BMY) stake by 197% in Q2 2026, buying an estimated $398K and bringing the position to 10,464 shares worth $603K. The position accounts for 0.17% of the portfolio, ranked #139.
West Family Investments first reported a position in BMY in Q2 2021 and has held it in 18 quarters since. The position peaked at $882K in Q4 2022. 1,973 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- West Family Investments held 10,464 shares of Bristol-Myers Squibb worth $603K as of Q2 2026.
- West Family Investments bought 6,936 Bristol-Myers Squibb shares in Q2 2026, an estimated $398K.
- Bristol-Myers Squibb made up 0.17% of West Family Investments's portfolio in Q2 2026, its #139 holding.
- West Family Investments first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 18 quarters since.
- West Family Investments's Bristol-Myers Squibb position peaked at $882K in Q4 2022.
- 1,973 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.